387 filings
Page 8 of 20
6-K
SCNI
Scinai Immunotherapeutics Ltd
23 Jun 21
BiondVax Announces First Quarter 2021 Financial Results and Provides Business Update
9:40am
6-K
SCNI
Scinai Immunotherapeutics Ltd
13 May 21
BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results
5:17pm
NT 20-F
SCNI
Scinai Immunotherapeutics Ltd
29 Apr 21
Notice of late annual filing (foreign)
10:05am
6-K
SCNI
Scinai Immunotherapeutics Ltd
6 Apr 21
Report of Foreign Private Issuer
9:45am
6-K
SCNI
Scinai Immunotherapeutics Ltd
23 Mar 21
Current Report
7:54am
6-K
SCNI
Scinai Immunotherapeutics Ltd
22 Mar 21
BiondVax Pharmaceuticals Ltd Company Presentation BiondVax Pharmaceuticals Ltd. | Jerusalem, Israel | www.biondvax.com www.biondvax.com March 2021
3:43pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
16 Mar 21
Report of Foreign Private Issuer
11:16am
6-K
SCNI
Scinai Immunotherapeutics Ltd
4 Mar 21
Report of Foreign Private Issuer
1:01pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
24 Feb 21
Current report (foreign)
4:53pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
17 Feb 21
Report of Foreign Private Issuer
4:42pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
11 Feb 21
BiondVax Announces Exercise in Full of Underwriter’s Over-Allotment Option in Follow-on Offering
6:30am
SC 13D/A
SCNI
Scinai Immunotherapeutics Ltd
9 Feb 21
BiondVax Pharmaceuticals / NACHT MARIUS ownership change
6:01am
6-K
SCNI
Scinai Immunotherapeutics Ltd
8 Feb 21
Current Report
2:54pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
2 Feb 21
BiondVax Announces Closing of $12.1 Million Follow-on Underwritten Offering
4:36pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
2 Feb 21
Report of Foreign Private Issuer
12:00am
424B5
SCNI
Scinai Immunotherapeutics Ltd
1 Feb 21
Prospectus supplement for primary offering
5:08pm
6-K
SCNI
Scinai Immunotherapeutics Ltd
29 Jan 21
BiondVax Announces Pricing of $12.1 Million Follow-on Underwritten Offering of American Depositary Shares
8:02am
424B5
SCNI
Scinai Immunotherapeutics Ltd
29 Jan 21
Prospectus supplement for primary offering
12:00am
6-K
SCNI
Scinai Immunotherapeutics Ltd
28 Jan 21
BiondVax Announces Launch of Proposed Underwritten Follow-on Offering of American Depositary Shares
9:29pm